Revision: Feb. 3, 2022, 1:53 p.m.
SB 414-FN-A - AS AMENDED BY THE SENATE
02/03/2022 0316s
2022 SESSION
22-2882
05/04
SENATE BILL 414-FN-A
AN ACT relative to the definition of Alzheimer's disease and related disorders.
SPONSORS: Sen. Avard, Dist 12; Sen. French, Dist 7; Sen. Gannon, Dist 23; Sen. Reagan, Dist 17; Sen. Carson, Dist 14; Sen. Rosenwald, Dist 13; Sen. Hennessey, Dist 1; Sen. Whitley, Dist 15; Sen. Watters, Dist 4; Sen. Soucy, Dist 18; Sen. Birdsell, Dist 19; Sen. Prentiss, Dist 5; Rep. Burt, Hills. 39; Rep. Ammon, Hills. 40; Rep. Hunt, Ches. 11; Rep. Knirk, Carr. 3
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill revises the definition of ADRD, Alzheimer's disease and related disorders.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
02/03/2022 0316s 22-2882
05/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Two
AN ACT relative to the definition of Alzheimer's disease and related disorders.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Alzheimer's Disease and Related Disorders. Amend RSA 161-F:66, I to read as follows:
I. "ADRD", Alzheimer's disease and related disorders, means [a condition which] conditions for which an individual receives a differential diagnosis of Alzheimer's disease or a similar irreversible dementia, or for which an individual demonstrates symptoms of Alzheimer's disease or a similar irreversible dementia to an extent such symptoms interfere with activities of daily living.
2 Effective Date. This act shall take effect July 1, 2022.
22-2882
Revised 1/17/22
SB 414-FN-A- FISCAL NOTE
AS INTRODUCED
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||
| Estimated Increase / (Decrease) | |||
STATE: | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
Appropriation | $0 | $1 | $0 | $0 |
Revenue | $0 | $0 | $0 | $0 |
Expenditures | $0 | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase |
Funding Source: | [ X ] General [ ] Education [ ] Highway [ ] Other | |||
METHODOLOGY:
This bill revises the definition of Alzheimer's disease and related disorders to include circumstances in which "an individual demonstrates symptoms of Alzheimer's disease or a similar irreversible dementia to an extent such symptoms interfere with activities of daily living." The Department of Health and Human Services states that the change is intended to capture situations in which individuals become symptomatic well before receiving a formal diagnosis, or in which individuals display symptoms but do not go to a doctor out of fear of a diagnosis. RSA 167-F:66 currently requires the Department to provide statewide respite care services to individuals, including those with Alzheimer's disease. The Department notes that it received $327,000 in FY 2021 and $302,508 each year of the FY 2022/23 biennium for the administration of respite care services. The Department further notes that 234 caregivers utilized respite funds in FY 2020, and 227 caregivers utilized such funds in FY 2021. The Department states that while it is unable to determine the number of additional caregivers who will seek funds as a result of the change contained in the bill, it expects that budgeted appropriations will be insufficient to fund care for all newly-eligible individuals.
This bill contains a nonlapsing appropriation of $1 for the biennium ending June 30, 2023. The bill has an effective date of July 1, 2022, so any fiscal impact will begin in FY 2023.
AGENCIES CONTACTED:
Department of Health and Human Services